Brian Meldrum, M.B.B. Chir., Ph.D.
Dr. Meldrum is Emeritus Professor of Experimental Neurology, GKT School of Biomedical Sciences, Guy's Campus, Kings College, London.
Within the past three years, Dr. Meldrum has been a consultant to Sanofi-Synthelabo.
This activity is made possible by an unrestricted educational grant from Forest Laboratories.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Describe the roles of glutamate ionotropic receptors in epileptic discharges and the changes in glutamate receptor function in acquired epilepsy in animals and man
- Describe the anticonvulsant effects in animal models of AMPA and NMDA receptor antagonists
- Discuss the effects of selective glutamate metabotropic agents on seizure phenomena.